Some studies suggest that, during CRC, overexpression of the genes EGFR and HER-2 results in the deregulation of this pathway, leading to increased cell proliferation, prolonged cell survival, anti-apoptotic effects, and metastasis [133]. Here, ERBB2 is linked to colorectal carcinoma.